TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30168131

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Quetiapine
Number of subjects: 0
Study: 26634774

Group type: EXPERIMENTAL
Intervention: Low-literacy action plan
Number of subjects: 119

Group type: COMPARATOR
Intervention: Standard action plan
Number of subjects: 119
Study: 24564723

Group type: EXPERIMENTAL
Intervention: Binocular training (average of 14.5 sessions over 4 to 6 weeks)
Number of subjects: 22
Study: 21827371

Group type: EXPERIMENTAL
Intervention: Attention training condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study: 20339846

Group type: EXPERIMENTAL
Intervention: TPO mimetics (romiplostim and eltrombopag)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatments
Number of subjects: 0
Study: 16522696

Group type: EXPERIMENTAL
Intervention: Oral conivaptan 40 mg/d
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Oral conivaptan 80 mg/d
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 12709315

Group type: EXPERIMENTAL
Intervention: Quinine + Rifampin
Number of subjects: 59

Group type: COMPARATOR
Intervention: Quinine alone
Number of subjects: 59
Study: 10922169

Group type: EXPERIMENTAL
Intervention: Vitek VK II system
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Christensen system
Number of subjects: 62

Group type: COMPARATOR
Intervention: Preoperative condition
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Postoperative condition
Number of subjects: 62

Group type: COMPARATOR
Intervention: Preoperative pain
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Postoperative pain
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Overall success rate
Number of subjects: 62
Study: 8928604

Group type: EXPERIMENTAL
Intervention: Desflurane with 50% nitrous oxide
Number of subjects: 53

Group type: COMPARATOR
Intervention: Propofol with 50% nitrous oxide
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 53
Study: 1570949

Group type: EXPERIMENTAL
Intervention: Hydrolyzed protein formula
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional modified milk formula
Number of subjects: 60
Study: 6242249

Group type: EXPERIMENTAL
Intervention: Total serum hexosaminidase levels in subjects with female genital cancers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta‐hexosaminidase levels in subjects with genital cancer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Total and beta‐hexosaminidase levels
Number of subjects: 0
Study: 31843375

Group type: EXPERIMENTAL
Intervention: SIMPL‐SYNC refill synchronization (SSRS)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 190
Study: 31456010

Group type: EXPERIMENTAL
Intervention: Combination of mizolastine (10 mg/day), proteoglycan (1.2 g, 3 times/day), calcium gluconate (10 mg/day), vitamin D3 (10 mg/week)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Combination of mizolastine and proteoglycan
Number of subjects: 100
Study: 28315567

Group type: EXPERIMENTAL
Intervention: Crossing septum guided by track image mapped by Carto3 system (track group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Crossing interatrial septum guided by fluoroscopy (trackless group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (track group and trackless group)
Number of subjects: 40
Study: 25497694

Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mg daily for 5 years
Number of subjects: 7154
Study: 23928867

Group type: EXPERIMENTAL
Intervention: Metformin added to intensive insulin therapy
Number of subjects: 33

Group type: COMPARATOR
Intervention: Insulin alone (control group)
Number of subjects: 33
Study: 20708320

Group type: EXPERIMENTAL
Intervention: Music-treated group
Number of subjects: 219

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 219
Study: 19538812

Group type: EXPERIMENTAL
Intervention: 300 g additional fruit and vegetables per day
Number of subjects: 276

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 276

Group type: COMPARATOR
Intervention: Potassium citrate
Number of subjects: 276
Study: 16488337

Group type: EXPERIMENTAL
Intervention: Efalizumab therapy
Number of subjects: 339
Study: 15465402

Group type: EXPERIMENTAL
Intervention: PDQL-EV questionnaire
Number of subjects: 137
Study: 11782701

Group type: EXPERIMENTAL
Intervention: Buflomedil
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 9875909

Group type: EXPERIMENTAL
Intervention: Gastric feeding
Number of subjects: 20

Group type: COMPARATOR
Intervention: Postpyloric feeding
Number of subjects: 20
Study: 8034151

Group type: EXPERIMENTAL
Intervention: Small group education
Number of subjects: 68

Group type: COMPARATOR
Intervention: Individual counselling
Number of subjects: 68
Study: 2659104

Group type: EXPERIMENTAL
Intervention: Salvage hormonal therapy
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Salvage chemotherapy
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Retreatment with CFP as salvage chemotherapy
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Salvage CFP
Number of subjects: 257
Study: 4281729

Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (unvaccinated children)
Number of subjects: 0
Study: 31113415

Group type: EXPERIMENTAL
Intervention: 1-hour intervention revealing safer sex option: dating same-age partners
Number of subjects: 229
Study: 28154373

Group type: EXPERIMENTAL
Intervention: Tiotropium + Olodaterol 2.5/5 or 5/5 μg
Number of subjects: 6783

Group type: COMPARATOR
Intervention: Tiotropium 2.5 or 5 μg
Number of subjects: 6783

Group type: COMPARATOR
Intervention: Olodaterol 5 μg
Number of subjects: 6783

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6783

Group type: EXPERIMENTAL
Intervention: Tiotropium + Olodaterol 5/5 μg
Number of subjects: 6783
Study: 25666530

Group type: EXPERIMENTAL
Intervention: Hypocaloric diet (7 ± 3% weight loss)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Gastric bypass surgery (33 ± 9% weight loss)
Number of subjects: 161
Study: 23385499

Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine and 1% thymol varnish (CervitecPlus)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: CervitecPlus + 0.2% chlorhexidine and 0.2% sodium fluoride (CervitecGel)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.1% fluoride varnish (Fluor Protector)
Number of subjects: 60
Study: 22018187

Group type: EXPERIMENTAL
Intervention: Prednisolone 5 mg/day
Number of subjects: 192

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study: 20467635

Group type: EXPERIMENTAL
Intervention: Immediate loading of implants
Number of subjects: 30

Group type: COMPARATOR
Intervention: Early loading of implants
Number of subjects: 30
Study: 16533077

Group type: EXPERIMENTAL
Intervention: Direct selection
Number of subjects: 120

Group type: COMPARATOR
Intervention: Visual linear scanning
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 3rd-grade children
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Retrieval errors
Number of subjects: 120
Study: 14652118

Group type: EXPERIMENTAL
Intervention: Propofol at a subhypnotic dose (1.0 mg/kg/hr)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Droperidol 1.25 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 100
Study: 11742887

Group type: EXPERIMENTAL
Intervention: Folic acid (5 mg) plus pyridoxine (250 mg)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study: 9420110

Group type: EXPERIMENTAL
Intervention: DCP without BG
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: DCP with BG
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Ender nails (EN)
Number of subjects: 91
Study: 8498758

Group type: EXPERIMENTAL
Intervention: Minocycline, 100 mg nightly for 7 days
Number of subjects: 253

Group type: COMPARATOR
Intervention: Doxycycline, 100 mg twice daily for 7 days
Number of subjects: 253
Study: 3281765

Group type: COMPARATOR
Intervention: Saline bolus followed by saline infusion
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 0.4 microgram.kg‐1 naloxone bolus followed by 0.4 microgram.kg‐1.hr‐1 naloxone infusion
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 2.0 micrograms.kg‐1 naloxone bolus followed by 2.0 micrograms.kg‐1.hr‐1 naloxone infusion
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 4.0 micrograms.kg‐1 naloxone bolus followed by 4.0 micrograms.kg‐1.hr‐1 naloxone infusion
Number of subjects: 29
Study: 30271119

Group type: EXPERIMENTAL
Intervention: Molecular targeted agents (MTAs)
Number of subjects: 4716

Group type: EXPERIMENTAL
Intervention: Brivanib
Number of subjects: 4716

Group type: EXPERIMENTAL
Intervention: Sorafenib
Number of subjects: 4716

Group type: EXPERIMENTAL
Intervention: Other molecular targeted agents (MTAs)
Number of subjects: 4716
Study: 29132441

Group type: EXPERIMENTAL
Intervention: Early screening and treatment for genital Chlamydia trachomatis infection over 24 months.
Number of subjects: 4000

Group type: COMPARATOR
Intervention: Control group with vaginal swabs analyzed at the end of the study following current recommendations.
Number of subjects: 4000
Study: 25160589

Group type: EXPERIMENTAL
Intervention: MK‐3577 (0‐900 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Glucagon, octreotide (Sandostatin), and basal insulin infusion
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Linear model for fasting plasma glucose (FPG)
Number of subjects: 36
Study: 22751354

Group type: EXPERIMENTAL
Intervention: Temporal Fast ForWord training (Group A)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-temporal control training (Group B)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-active controls (Group C)
Number of subjects: 30
Study: 20017187

Group type: EXPERIMENTAL
Intervention: Intervention (4-month prospective study)
Number of subjects: 247

Group type: COMPARATOR
Intervention: High perceived physical workload or overtime work
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Higher baseline pain intensity, Hispanic ethnicity, and taking cumulative daily rest time of 35 min or more
Number of subjects: 247
Study: 17351226

Group type: EXPERIMENTAL
Intervention: Intubating Laryngeal Mask Airway (ILMA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Mackintosh laryngoscope
Number of subjects: 100
Study: 16244851

Group type: EXPERIMENTAL
Intervention: Health telephone surveys
Number of subjects: 8313
Study: 11889385

Group type: EXPERIMENTAL
Intervention: Mastoid pneumatization measurement (size measured by simplified rectangular dimension method on a mastoid x-ray)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ears with barotrauma
Number of subjects: 24
Study: 9459076

Group type: EXPERIMENTAL
Intervention: Negative search condition
Number of subjects: 30

Group type: COMPARATOR
Intervention: Positive search condition
Number of subjects: 30

Group type: COMPARATOR
Intervention: Known intervals search condition
Number of subjects: 30
Study: 9497653

Group type: EXPERIMENTAL
Intervention: Tetracycline‐Hcl solution 100 mg/ml for 5 minutes
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control group (no tetracycline irrigation)
Number of subjects: 7
Study: 2559794

Group type: EXPERIMENTAL
Intervention: Phyllanthus amarus extract, administered orally for 1 month
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phyllanthus amarus extract, administered intraperitoneally
Number of subjects: 0
Study: 370685

Group type: EXPERIMENTAL
Intervention: Modified neurotoxin
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 30824257

Group type: EXPERIMENTAL
Intervention: CAU + online intervention (mindfulness-based compassionate living, MBCL)
Number of subjects: 122

Group type: COMPARATOR
Intervention: CAU (care as usual)
Number of subjects: 122
Study: 27219124

Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C (3 g in 500 mL of Ringer)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline (6 mL in 500 mL of Ringer)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (Vitamin C and Normal Saline)
Number of subjects: 40
Study: 24820007

Group type: EXPERIMENTAL
Intervention: Bovine pericardium mesh
Number of subjects: 40

Group type: COMPARATOR
Intervention: Routine abdominal suture closure (Control)
Number of subjects: 40
Study: 23643338

Group type: EXPERIMENTAL
Intervention: SS‐SSTP (Second Step: Student Success Through Prevention)
Number of subjects: 3616

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 3616
Study: 20350769

Group type: EXPERIMENTAL
Intervention: Lipid-lowering treatment (LLT) group, including statin and/or fibrate
Number of subjects: 510

Group type: COMPARATOR
Intervention: No-Lipid-lowering treatment (No-LLT) group
Number of subjects: 510
Study: 19269925

Group type: EXPERIMENTAL
Intervention: Cognitive remediation + vocational rehabilitation
Number of subjects: 34

Group type: COMPARATOR
Intervention: Vocational rehabilitation alone
Number of subjects: 34
Study: 16643536

Group type: EXPERIMENTAL
Intervention: Carisolv
Number of subjects: 40

Group type: COMPARATOR
Intervention: High-speed excavation
Number of subjects: 40
Study: 12671333

Group type: EXPERIMENTAL
Intervention: Vigorous treatment of hypertension and use of converting‐enzyme inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Angiotensin receptor blockers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Various drugs
Number of subjects: 0
Study: 12497780

Group type: EXPERIMENTAL
Intervention: Indapamide 1.5 mg daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enalapril 20 mg daily
Number of subjects: 0
Study: 7549804

Group type: EXPERIMENTAL
Intervention: Carotenoid diet (carrots and spinach)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Cruciferous diet (broccoli and cauliflower)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control diet (essentially carotenoid free)
Number of subjects: 19
Study: 1718694

Group type: EXPERIMENTAL
Intervention: Intrarenal gallopamil plus intravenous furosemide (0.5 mg/kg/h for 24 hours)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Furosemide alone
Number of subjects: 10
Study: 6958406

Group type: EXPERIMENTAL
Intervention: Combination of preventive regimens including fluoridated water ingestion, oral hygiene education, dental examinations, prophylaxis, acidulated phosphate fluoride gel (1.23%), pit and fissure sealants, and restorative care
Number of subjects: 1286

Group type: EXPERIMENTAL
Intervention: Treatment group that continued with preventive regimens
Number of subjects: 1286

Group type: COMPARATOR
Intervention: Treatment group that did not continue with treatment after 3 years
Number of subjects: 1286
Study: 31297906

Group type: EXPERIMENTAL
Intervention: Family-based treatment (FBT)
Number of subjects: 68
Study: 31294447

Group type: EXPERIMENTAL
Intervention: Homologous recombination (HR) pathway
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Double Holliday junction (dHJ) pathway
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Synthesis-dependent strand annealing (SDSA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Break-induced replication (BIR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single-strand annealing (SSA)
Number of subjects: 0
Study: 28610582

Group type: EXPERIMENTAL
Intervention: Balance training for 5 weeks
Number of subjects: 28

Group type: COMPARATOR
Intervention: Habitual activity (control group)
Number of subjects: 28
Study: 26238090

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 0
Study: 23359237

Group type: EXPERIMENTAL
Intervention: 80% fraction of inspired oxygen (FIO2)
Number of subjects: 160

Group type: COMPARATOR
Intervention: 30% fraction of inspired oxygen (FIO2)
Number of subjects: 160
Study: 22080021

Group type: EXPERIMENTAL
Intervention: 100% millet inclusion
Number of subjects: 432

Group type: COMPARATOR
Intervention: Millet growth condition
Number of subjects: 432

Group type: COMPARATOR
Intervention: Millet inclusion level
Number of subjects: 432
Study: 18359416

Group type: EXPERIMENTAL
Intervention: Candida colonization
Number of subjects: 639
Study: 16484309

Group type: EXPERIMENTAL
Intervention: Ibuprofen (1200 mg daily during menses for up to 5 days each cycle for the first 6 months)
Number of subjects: 2019

Group type: COMPARATOR
Intervention: Placebo (identical appearing, taken in the same manner)
Number of subjects: 2019
Study: 14509555

Group type: EXPERIMENTAL
Intervention: Salmeterol
Number of subjects: 623

Group type: EXPERIMENTAL
Intervention: Tiotropium
Number of subjects: 623

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 623
Study: 10696889

Group type: EXPERIMENTAL
Intervention: Transanally introduced stapling technique
Number of subjects: 35

Group type: COMPARATOR
Intervention: Biofragmentable anastomotic ring
Number of subjects: 35
Study: 9236896

Group type: EXPERIMENTAL
Intervention: Histamine concentration in colorectal cancer tissue
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Histamine concentration
Number of subjects: 31
Study: 1546993

Group type: EXPERIMENTAL
Intervention: Interactive-videodisc computer lab
Number of subjects: 473

Group type: COMPARATOR
Intervention: Traditional cadaver-demonstration lab
Number of subjects: 473
Study: 2864937

Group type: EXPERIMENTAL
Intervention: etilefrine pivalate (Ep, 20 mg p.o.)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: dihydroergotamine (DHE, 5 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24
Study: 29471032

Group type: EXPERIMENTAL
Intervention: School-based telemedicine asthma education intervention
Number of subjects: 393

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 393
Study: 27341683

Group type: EXPERIMENTAL
Intervention: Q-Switched Ruby Laser (QSRL)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Triple Combination Therapy (TCT)
Number of subjects: 15
Study: 25170594

Group type: EXPERIMENTAL
Intervention: Short-term preseasonal allergoid immunotherapy
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 23787227

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioural therapy (iCBT) program (the Sadness Program)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Lower distress tolerance scores at baseline
Number of subjects: 109
Study: 20595412

Group type: EXPERIMENTAL
Intervention: Adjunctive SAMe (800 mg/twice daily)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Adjunctive placebo
Number of subjects: 73
Study: 18940900

Group type: EXPERIMENTAL
Intervention: plasma total homocysteine (tHcy)
Number of subjects: 923

Group type: EXPERIMENTAL
Intervention: plasma folate concentrations
Number of subjects: 923
Study: 16905077

Group type: EXPERIMENTAL
Intervention: L-O (lidocaine with occlusion of IV flow)
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: L-F (lidocaine with free IV flow)
Number of subjects: 350

Group type: COMPARATOR
Intervention: C-O (control with occlusion of IV flow)
Number of subjects: 350

Group type: COMPARATOR
Intervention: C-F (control with free IV flow)
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: S (sodium bicarbonate with placebo pretreatment)
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: L (lidocaine pretreatment)
Number of subjects: 350

Group type: COMPARATOR
Intervention: P (placebo pretreatment)
Number of subjects: 350
Study: 12959741

Group type: EXPERIMENTAL
Intervention: Endogenous digoxin, dolichol, and ubiquinone levels in patients with inflammatory bowel disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tryptophan/tyrosine catabolic patterns in patients with inflammatory bowel disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cholesterol:phospholipid ratio and glycoconjugate level of RBC membrane in patients with inflammatory bowel disease
Number of subjects: 0
Study: 12419298

Group type: EXPERIMENTAL
Intervention: Biventricular pacing
Number of subjects: 59

Group type: COMPARATOR
Intervention: Univentricular pacing
Number of subjects: 59
Study: 11720639

Group type: EXPERIMENTAL
Intervention: Dalteparin (120 IU/kg subcutaneously twice daily for more than 6 days)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Dalteparin
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group (Unfractionated heparin)
Number of subjects: 3
Study: 8924306

Group type: EXPERIMENTAL
Intervention: Exosurf (2 x 5 mL/kg doses given 12 h apart, first dose at mean age of 18.7 +/- 3.4 h)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control group (no surfactant given)
Number of subjects: 2
Study: 2201733

Group type: EXPERIMENTAL
Intervention: Zopiclone
Number of subjects: 6
Study: 6127028

Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30785830

Group type: EXPERIMENTAL
Intervention: Whole-brain radiotherapy (WBRT) delivered 40 Gy (2 Gy/fraction)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy and autologous stem-cell transplantation (ASCT)
Number of subjects: 140
Study: 29021207

Group type: COMPARATOR
Intervention: Lifestyle intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metformin intervention
Number of subjects: 0
Study: 25710565

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (LDA; 81 mg/day)
Number of subjects: 1228

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1228
Study: 24142681

Group type: EXPERIMENTAL
Intervention: Group 1 (G1), without any anti‐arrhythmic drug (AAD)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Group 2 (G2), with amiodarone or sotalol
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Group 3 (G3), with last ineffective AAD
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Overall results after 55 months follow-up
Number of subjects: 210
Study: 21956713

Group type: EXPERIMENTAL
Intervention: Oral cholecalciferol 150,000 IU every 3 months (n=353)
Number of subjects: 686

Group type: COMPARATOR
Intervention: Placebo (n=333)
Number of subjects: 686

Group type: EXPERIMENTAL
Intervention: Oral cholecalciferol 150,000 IU every 3 months
Number of subjects: 686

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 686
Study: 19638596

Group type: EXPERIMENTAL
Intervention: Nonprescription nicotine replacement therapy (NRT)
Number of subjects: 646

Group type: EXPERIMENTAL
Intervention: Cigarettes
Number of subjects: 646

Group type: EXPERIMENTAL
Intervention: NRT
Number of subjects: 646

Group type: EXPERIMENTAL
Intervention: NRT and cigarettes
Number of subjects: 646